Sydney W. Tang

Pok Fu Lam Road DD3LM 1969
Pok Fu Lam, Hong Kong Special Administrative Region

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 233 publications

Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial.

Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: September 04, 2026

Herpes zoster and respiratory syncytial virus vaccination in patients with cardiovascular-kidney-metabolic syndrome in Hong Kong.

Herpes zoster and respiratory syncytial virus vaccination in patients with cardiovascular-kidney-metabolic syndrome in Hong Kong.

Journal: Hong Kong medical journal = Xianggang yi xue za zhi

Published: August 24, 2026

C5a/C5aR1 mediates AKI-CKD transition by enhancing autophagy.

C5a/C5aR1 mediates AKI-CKD transition by enhancing autophagy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: July 10, 2026

Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial.

Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial.

Journal: JAMA

Published: June 05, 2026

The versatile roles of long non-coding RNAs in kidney disease.

The versatile roles of long non-coding RNAs in kidney disease.

Journal: Nature reviews. Nephrology

Published: May 29, 2026

Kidney Injury Associated with Monoclonal Gammopathy: A Nephrologist's Perspective.

Kidney Injury Associated with Monoclonal Gammopathy: A Nephrologist's Perspective.

Journal: Kidney360

Published: May 26, 2026

Peritonitis and Mortality Risks of Gastric Acid Suppressants in Patients Undergoing Peritoneal Dialysis.

Peritonitis and Mortality Risks of Gastric Acid Suppressants in Patients Undergoing Peritoneal Dialysis.

Journal: Kidney international reports

Published: May 01, 2026

Effect of Folate-Based Supplementation in Kidney Disease: A Systematic Review and Meta-analysis of Kidney, Cardiovascular, and Mortality Outcomes.

Effect of Folate-Based Supplementation in Kidney Disease: A Systematic Review and Meta-analysis of Kidney, Cardiovascular, and Mortality Outcomes.

Journal: Nutrition reviews

Published: March 26, 2026

Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Journal: Kidney international

Published: February 05, 2026

Current understanding of sodium-glucose transporter 2 inhibitors in cardiovascular-kidney-metabolic syndrome.

Current understanding of sodium-glucose transporter 2 inhibitors in cardiovascular-kidney-metabolic syndrome.

Journal: Frontiers in pharmacology

Published: January 31, 2026

Comparative performance of risk prediction models for kidney disease: an external validation using 0.5 million UK Biobank participants.

Comparative performance of risk prediction models for kidney disease: an external validation using 0.5 million UK Biobank participants.

Journal: BMC nephrology

Published: January 28, 2026

Complement inhibitors and B cell-modifying agents for IgA nephropathy-a Kidney Disease: Improving Global Outcomes (KDIGO) commentary.

Complement inhibitors and B cell-modifying agents for IgA nephropathy-a Kidney Disease: Improving Global Outcomes (KDIGO) commentary.

Journal: Kidney international

Published: January 28, 2026

Showing 1-12 of 233

Last Updated: 09/26/2026